| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 950.80M | 906.85M | 705.75M | 534.70M | 476.40M | 566.29M |
| Gross Profit | 146.00M | 141.84M | 133.11M | 83.38M | 128.59M | 181.02M |
| EBITDA | 62.18M | 67.64M | 76.03M | 29.39M | 53.20M | 100.15M |
| Net Income | 52.87M | 51.30M | 43.58M | 22.32M | 35.23M | 40.52M |
Balance Sheet | ||||||
| Total Assets | 1.64B | 1.69B | 1.39B | 1.15B | 933.76M | 859.60M |
| Cash, Cash Equivalents and Short-Term Investments | 24.90M | 33.90M | 32.47M | 53.74M | 26.50M | 54.44M |
| Total Debt | 588.24M | 640.75M | 712.97M | 638.51M | 360.40M | 282.99M |
| Total Liabilities | 1.14B | 1.25B | 979.45M | 775.84M | 553.99M | 532.82M |
| Stockholders Equity | 500.42M | 447.03M | 409.18M | 372.64M | 377.76M | 317.25M |
Cash Flow | ||||||
| Free Cash Flow | 152.28M | 87.26M | -80.23M | -119.92M | -124.46M | -83.10M |
| Operating Cash Flow | 180.84M | 191.69M | 30.00M | 41.86M | 6.44M | 13.59M |
| Investing Cash Flow | -87.84M | -133.17M | -139.95M | -157.54M | -110.16M | -77.50M |
| Financing Cash Flow | -76.96M | -44.65M | 94.22M | 142.02M | 68.61M | 64.81M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$433.39M | 4.48 | 17.17% | 8.49% | 21.99% | 11.36% | |
73 Outperform | HK$312.29M | 2.48 | 19.34% | ― | -3.12% | 1.92% | |
70 Outperform | HK$288.96M | 12.72 | 5.51% | 6.61% | -34.28% | -45.72% | |
66 Neutral | HK$359.01M | 6.31 | 10.92% | ― | 11.10% | -4.38% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | HK$295.66M | 9.85 | 3.77% | 10.32% | -6.67% | -29.55% | |
53 Neutral | HK$1.07B | -18.26 | ― | ― | -45.11% | -48.30% |
China Ludao Technology Co. Ltd. announced that its subsidiary, Zhejiang Sinopharm Junyue Aerosol Co., Ltd, has received a Work Safety Licence for Hazardous Chemicals from the Zhejiang Provincial Department of Emergency Management. This development allows the subsidiary to legally manufacture aerosol products across nine categories of hazardous chemicals, marking a significant advancement in the company’s strategic positioning within the aerosol industry. The license is expected to boost the company’s production capacity and competitiveness in global high-end markets, supporting its rapid expansion and commitment to quality development in the industry.